StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.29+0.02 (+0.07%)

Close on Nov 18, 2026Market cap $1.69BP/E –Yield –

Kestra Medical Technologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Kestra Medical Technologies's revenue for the twelve months ending Jul 31, 2026 was $106.73M, up 60.7% year over year. For fiscal 2026 it was $95.13M, up 59.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2026Apr 30, 2026$95.13M+59.0%
FY2025Apr 30, 2025$59.82M+115.1%
FY2024Apr 30, 2024$27.81M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$30.97M+59.9%
Q4 FY2026CQ1 2026Apr 30, 2026$28.64M+66.2%
Q3 FY2026CQ4 2025Jan 31, 2026$24.55M+62.7%
Q2 FY2026CQ3 2025Oct 31, 2025$22.57M+53.4%
Q1 FY2026CQ2 2025Jul 31, 2025$19.37M+51.5%
Q4 FY2025CQ1 2025Apr 30, 2025$17.23M–
Q3 FY2025CQ4 2024Jan 31, 2025$15.09M–
Q2 FY2025CQ3 2024Oct 31, 2024$14.71M–
Q1 FY2025CQ2 2024Jul 31, 2024$12.78M–

More Kestra Medical Technologies figures

See a number that looks wrong?